SGMT

Sagimet Biosciences Inc

May 20 • 11:45AM ET

6.59

+0.05 0.76 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IVA ALT TERN ENTA MDGL

| Held by: VTI VXF IBB DFAS IWC AVSC DFMC DFAC DCOR DFSU

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.34	Insider Own	6.22%	Shs Outstand	61.75M	Perf Week	-13.29%
Market Cap	403.21M	Forward P/E	-	EPS next Y	-1.25	Insider Trans	-1.48%	Shs Float	57.91M	Perf Month	11.51%
Enterprise Value	298.71M	PEG	-	EPS next Q	-0.25	Inst Own	20.75%	Short Float	7.83%	Perf Quarter	22.49%
Income	-43.51M	P/S	-	EPS this Y	24.06%	Inst Trans	-0.61%	Short Ratio	3.22	Perf Half Y	-15.62%
Sales	0.00M	P/B	2.10	EPS next Y	-4.23%	ROA	-34.27%	Short Interest	4.53M	Perf YTD	11.32%
Book/sh	3.14	P/C	3.86	EPS next 5Y	-0.98%	ROE	-36.04%	52W High	11.41 -42.24%	Perf Year	92.13%
Cash/sh	1.71	P/FCF	-	EPS past 3/5Y	-3.41% -24.29%	ROIC	-42.47%	52W Low	3.15 109.21%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.33% 9.00%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	24.50%	Oper. Margin	-	ATR (14)	0.53	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	20.26	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	45.11	Recom	1.17
Dividend Gr. 3/5Y	- -	Current Ratio	20.26	EPS Q/Q	42.07%	SMA20	-11.66%	Beta	3.61	Target Price	26.50
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	6.34%	Rel Volume	0.25	Prev Close	6.54
Employees	16	LT Debt/Eq	0.00	Earnings	May 12 BMO	SMA200	-1.11%	Avg Volume	1.41M	Price	6.59
IPO	Jul 14, 2023	Option/Short	Yes / Yes	EPS/Sales Surpr.	11.03% -	Trades		Volume	135,703	Change	0.76%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)